Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Clinical Trials
2 recruitingBiologic
Early Phase 11Phase 11
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAdenovirusCytomegalovirus+2 more
Sumithira Vasu20 enrolled2 locationsNCT03665675
Recruiting
Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Hematopoietic and Lymphoid Cell NeoplasmImmunocompromised
M.D. Anderson Cancer Center16 enrolled1 locationNCT03425526